Lupin’s Problems Mount As U.S. Plant Classified As ‘Official Action Indicated’

The company said its plant in Somerset, New Jersey was classified as “official action indicated” after an inspection by U.S. FDA.

An employee inspects tablets at the Lupin Ltd. pharmaceutical plant in Goa, India. (Photographer: Dhiraj Singh/Bloomberg)

Lupin Ltd. said that its plant in Somerset, New Jersey was classified as “official action indicated” after an inspection by the U.S. Food and Drug Administration.

Watch LIVE TV, Get Stock Market Updates, Top Business, IPO and Latest News on NDTV Profit.
GET REGULAR UPDATES